These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [H. pylori eradication therapy and natural history of peptic ulcer]. Haruma K; Kamada T; Kusunoki H Nihon Rinsho; 2002 Feb; 60 Suppl 2():49-53. PubMed ID: 11979833 [No Abstract] [Full Text] [Related]
24. [Peptic ulcer recurrent in patients following successful eradication of Helicobacter pylori]. Horiki N; Fujita Y; Maruyama M; Imoto I; Ogura A; Kuroda M; Nakamura M; Adachi Y Nihon Rinsho; 2005 Nov; 63 Suppl 11():508-11. PubMed ID: 16363590 [No Abstract] [Full Text] [Related]
25. [Peptic ulcer in patients with diabetes mellitus]. Sato T; Kitahara F; Nakamura T; Kojima Y; Fujino MA Nihon Rinsho; 2002 Aug; 60(8):1580-4. PubMed ID: 12187754 [TBL] [Abstract][Full Text] [Related]
26. [Reflections on the marked changes of the prevalence of Helicobacter pylori infection and peptic ulcer disease in the last two decades]. Bohumil F Cas Lek Cesk; 2011; 150(2):91-3. PubMed ID: 21560446 [TBL] [Abstract][Full Text] [Related]
27. [Epidemiology and risk factors of gastroduodenal ulcer]. Kreiss C; Blum AL Chirurg; 1996 Jan; 67(1):7-13. PubMed ID: 8851669 [TBL] [Abstract][Full Text] [Related]
28. How to manage the dyspeptic patient. Vaira D Helicobacter; 1996 Dec; 1(4):261-2. PubMed ID: 9398879 [No Abstract] [Full Text] [Related]
29. [Management of complicated and non complicated gastric and duodenal ulcer disease]. Cadiot G Gastroenterol Clin Biol; 1999 Oct; 23(10 Pt 2):C34-47. PubMed ID: 10880914 [No Abstract] [Full Text] [Related]
30. [The role for Helicobacter pylori infection in intractable and recurrent ulcer]. Kubota T; Ito A; Shiota K; Fujioka T Nihon Rinsho; 1993 Dec; 51(12):3221-6. PubMed ID: 8283637 [TBL] [Abstract][Full Text] [Related]
31. [Peptic ulcer and environmental factor: with special focus on Helicobacter pylori infection]. Tatemichi M; Tsugane S Nihon Rinsho; 2002 Feb; 60 Suppl 2():179-83. PubMed ID: 11979773 [No Abstract] [Full Text] [Related]
35. Helicobacter pylori infection in Japan: current status and future options. Graham DY; Kimura K; Shimoyama T; Takemoto T Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S1-4. PubMed ID: 7735923 [TBL] [Abstract][Full Text] [Related]
36. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062 [TBL] [Abstract][Full Text] [Related]
37. [Decreasing prevalence and incidence of ulcerative disease--an amazing phenomenon of the end of XX and the beginning of the XXI century]. Vasil'ev IuV Eksp Klin Gastroenterol; 2010; (9):73-6. PubMed ID: 21427929 [TBL] [Abstract][Full Text] [Related]
38. [Relationship between NSAIDs and H. pylori in peptic ulcer diseases--is the eradication of H. pylori recommended in NSAIDs ulcer?]. Ota S; Nakajima S; Bamba H Nihon Rinsho; 2005 Nov; 63 Suppl 11():565-8. PubMed ID: 16363602 [No Abstract] [Full Text] [Related]